Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES)

por Barratt, Jonathan, Andric, Branislav, Tataradze, Avtandil, Schömig, Michael, Reusch, Michael, Valluri, Udaya, Mariat, Christophe
Publicado 2021

Efficacy and Cardiovascular Safety of Roxadustat in Dialysis-Dependent Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies

por Barratt, Jonathan, Sulowicz, Wladyslaw, Schömig, Michael, Esposito, Ciro, Reusch, Michael, Young, James, Csiky, Botond
Publicado 2021

Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study...

por Csiky, Botond, Schömig, Michael, Esposito, Ciro, Barratt, Jonathan, Reusch, Michael, Valluri, Udaya, Sulowicz, Wladyslaw
Publicado 2021

Erratum to: Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: A Phase 3, randomised, open-label, active-controlled study (DOLOMITES)

por Barratt, Jonathan, Andric, Branislav, Tataradze, Avtandil, Schömig, Michael, Reusch, Michael, Valluri, Udaya, Mariat, Christophe
Publicado 2022

Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies

por Topf, Joel, Wooldridge, Thomas, McCafferty, Kieran, Schömig, Michael, Csiky, Botond, Zwiech, Rafal, Wen, Warren, Bhaduri, Sarbani, Munera, Catherine, Lin, Rong, Jebara, Alia, Cirulli, Joshua, Menzaghi, Frédérique
Publicado 2022